Introduction {#s1}
============

Sertoli cells are the first somatic cell type to differentiate in the testis and the only somatic cell type inside the seminiferous tubules. Sertoli cells play a critical role in directing testis morphogenesis and the creation of an immune-privileged microenvironment, which is required for male germ cell development. During early gonad development, male somatic cells express the male sex-determining gene *SRY*, which directs the sex-specific vascular development and seminiferous cord formation ([@bib2]; [@bib7]; [@bib32]) via the initiation of a cascade of genes, including *SOX9, FGF9, AMH* and *PGD2* ([@bib1]; [@bib40]). *NR5A1* (or *SF1*), *GATA4*, and *WT1* are major transcriptional factors that direct somatic cells to become fetal Sertoli cells ([@bib45]). Five transcriptional factors have been demonstrated to successfully reprogram mouse fibroblasts to Sertoli cells ([@bib8]). The expanding fetal Sertoli cells and another type of testicular somatic cell (i.e., peritubular cells) regulate the final organization and morphogenesis of the developing gonad into a testis ([@bib19]; [@bib37]).

Sertoli cells are the pivotal somatic cell regulators inside the seminiferous cord. Sertoli cells embed male germ cells during all differentiating stages and provide immunological, nutritional and structural support for germ cell development ([@bib43]). Sertoli cells secrete the growth factors and cytokines needed for proper spermatogenesis, including the maintenance of spermatogonial stem cells, meiosis initiation of spermatocytes, and maturation of spermatozoa ([@bib21]). Furthermore, Sertoli cells have the unique ability to modulate immunoreactions that protect the developing germ cells from immunological attacks. The immune-privileged potential of Sertoli cells has been utilized in many allo- and xeno-grafts to reduce the immune response in the field of cell transplantation ([@bib29]; [@bib39]; [@bib51]). Preclinical studies have transplanted Sertoli cells with various other cell types for the treatment of diabetes, neurodegenerative diseases, Duchenne muscular dystrophy, skin allografts and other diseases ([@bib36]).

Recently, co-cultures of differentiated rodent primordial germ cells and neonatal testicular somatic cells have successfully enabled meiosis completion and round spermatid formation in vitro ([@bib63]), highlighting the potential use of testicular somatic cells in the field of reproductive medicine although more experimental validations and improvements are needed. Human pluripotent stem cells have been differentiated to spermatid-like cells ([@bib15]; [@bib30]), but the co-culturing of stem cells with Sertoli cells could enhance the efficiencies of obtaining functional male gametes. However, the procurement of human Sertoli cells is not feasible because of biological and ethical constraints. The availability of donated Sertoli cells is limited, and expanding the limited number of human Sertoli cells in vitro remains a challenge ([@bib9]; [@bib33]). Therefore, the generation of Sertoli cells from fibroblasts could alleviate these issues and fulfill the basic research and clinical demands.

Direct lineage reprogramming has been considered a promising strategy for obtaining functional cell types with lower teratoma risks than directed differentiation of pluripotent stem cells ([@bib10]; [@bib59]). The induction of cell type conversion between divergent lineages has been achieved using combinations of lineage-specific transcription factors ([@bib22]; [@bib23]; [@bib42]; [@bib60]). Fibroblasts are common cells in animal connective tissues that can be conveniently obtained from patients. Therefore, fibroblasts are often used as initiating cells in many lineage reprogramming experiments. The direct reprogramming of Sertoli cells from fibroblasts has been demonstrated in mouse ([@bib8]), but the direct lineage conversion of human Sertoli cells from fibroblasts has not been described. Here, we report the efficient induction of human Sertoli cells (hiSCs) from both primary human fibroblasts and fibroblasts derived from human embryonic stem cells (hESCs). These hiSCs exhibit an epithelial morphology, lipid droplet accumulation, and transcriptomes similar to those of primary Sertoli cells; sustain the growth of mouse spermatogonia cells; and perform immune-privileged function during transplantation experiments.

Connexin 43 (CX43) is a predominant gap junction protein expressed in BTBs that affects the maturation of Sertoli cells and spermatogenesis ([@bib6]; [@bib17]; [@bib49]; [@bib57]). The deletion of *CX43* in Sertoli cells, but not germ cells, causes infertility in mice ([@bib6]; [@bib20]). The absence of CX43 expression in human Sertoli cells is associated with Sertoli cell-only syndrome (SCO) and impaired spermatogenesis in male patients ([@bib5]; [@bib14]), but whether the deletion of *CX43* directly affects the characteristics of human Sertoli cells has not been demonstrated. Utilizing our in vitro hiSC model, we demonstrate that the deletion of *CX43* affects the transcriptome profile and maturation of hiSCs.

Results {#s2}
=======

Testing the reprogramming capability of five putative transcriptional factors {#s2-1}
-----------------------------------------------------------------------------

Based on the reprogramming capability of the transcriptional factors reported in a mouse study ([@bib8]), we first tested the reprogramming capabilities of the human homologs of the five transcriptional factors (5TFs: NR5A1, GATA4, WT1, SOX9 and DMRT1) to convert human fibroblasts to hiSCs. All five human homologs were correctly cloned into lentiviral vectors and expressed at high levels as verified by immunofluorescent staining of HPFs and transcriptional level in human embryonic kidney cells ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). After the lentiviral transduction with all five factors and culturing in selective medium for 5 days ([Figure 1B](#fig1){ref-type="fig"}), many HPFs started to transform from the typical elongated morphology of fibroblasts into the squamous morphology that typically appears in epithelial cells ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). The analysis of the transcriptional expression showed that genes enriched in mesenchymal-to-epithelial transition ([@bib8]; [@bib35]; [@bib46]), including *MUC1*, *CLDN1*, *CLDN7*, *CLDN11 and TJP1*, exhibited increased expression in this mixed population of transformed HPFs ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). In addition, the transcriptional expression of genes enriched in Sertoli cells, such as *AR, KRT18*, *CLU*, *PTGDS*, *SCF*, *BMP4 and INHA*, exhibited increased expression in this mixed population of transformed HPFs ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). To determine whether these 5TFs were able to reprogram other fibroblast sources, we derived human fibroblast-like cells from hESC line H1 (dH1) and reprogrammed these cells as described for the HPFs. The dH1 morphology resembled that of fibroblasts, and no detectable expression of pluripotent markers was observed, but the expression of many markers of fibroblasts was observed ([Figure 1---figure supplement 2A, B and C](#fig1s2){ref-type="fig"}). After the transduction of the 5TFs, dH1 underwent a fibroblast to epithelial transformation similar to that observed in the HPFs ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}), suggesting that the 5TFs can transform both types of fibroblasts into epithelial-like cells and increase the expression of Sertoli cell markers.

![Induction of Sertoli-like cells (hiSCs) from human fibroblasts.\
(**A**) Immunostaining of NR5A1, GATA4, WT1, SOX9 and DMRT1 (red signal) in fibroblasts (HPF) 3 days post infection. DAPI (blue signal) was used to indicate nucleus. Scale bar = 25 μm. NC represents HPF stained with only secondary antibody. (**B**) Experimental design for the reprogramming of human Sertoli-like cells (hiSCs). Human fibroblasts were infected by lentivirus carrying human transcription factors: NR5A1, GATA4, WT1, SOX9 and DMRT1 (5TFs). The cells were cultured in MEF medium for 1 day after infection and followed by G418 selection for 5 days, then changed to DMEM/F12 medium. hiSCs were characterized 10--14 days post viral transduction. (**C**) Schematic protocol for the enrichment of Sertoli-like cells (hiSCs). An AMH:EGFP reporter was integrated to the fibroblasts for hiSCs quantification and isolation. (**D**) FACS analysis of AMH:EGFP+ cell at day 10 after 5TFs infection. The percentage of EGFP+ cell was used to determine the reprogramming efficiency. Two types of human fibroblasts (HPF and dH1) were tested. Cells infected by p2k7 empty virus were used as negative control (CTRL). (**D**) Morphology of re-plated AMH:EGFP+ hiSCs after FACS. Scale bar = 20 μm. (**F**) The mRNA level of AMH was enriched in AMH:EGFP+ hiSCs, as compared to dH1 infected by p2k7 empty virus (dH1-2K7) and AMH:EGFP-. n = 3, technical replicates of \~5 × 10^4^ cells were collected by FACS. All data are presented as means ± SD. \*p\<0.05, \*\*p\<0.01, Student's t-test.\>3 independent experiments were carried out. (**G**) Immunofluorescent staining of KRT18 in AMH:EGFP+ hiSCs and dH1 infected by p2k7 empty virus (dH1-2K7) after FACS. Scale bar = 100 μm.](elife-48767-fig1){#fig1}

To isolate and enrich the hiSCs in the mixed population of reprogrammed fibroblasts, we constructed a gene reporter system utilizing the 1.6 kb promoter region of *AMH*, which is a gene specifically expressed in Sertoli cells ([@bib16]), connected to EGFP ([Figure 1C](#fig1){ref-type="fig"}). Recent report of single-cell transcriptome analysis also confirms that AMH is specifically expressed in Sertoli cells but not other somatic cells of adult human testis ([@bib56]). We constructed a gene reporter carrying *AMH* promoter fusing to EGFP gene and transduced the reporter into adult human Sertoli cells to confirm EGFP expression ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). When the lentivector carrying the reporter, AMH:EGFP, was stably integrated into HPFs and dH1, none of the cells would express EGFP without transcriptional induction. After the transduction and selection of the fibroblasts, some reprogrammed cells were expected to express EGFP to allow us to isolate them by fluorescence-activated cell sorting (FACS). We found that both HPF and dH1 reproducibly yielded a clear AMH:EGFP-positive population after 10 days of transduction with the 5TFs ([Figure 1D](#fig1){ref-type="fig"}). Intriguingly, the AMH:EGFP+ population in the dH1 group (\~15%) was much higher than that in the HPF group (\~6%), indicating that the conversion of the dH1 cells was more efficient. The AMH:EGFP+ cells were isolated by FACS and adhered to culture dishes and exhibited an epithelial morphology ([Figure 1E](#fig1){ref-type="fig"}). We verified that the endogenous AMH expression was activated because the expression level of the *AMH* gene was significantly upregulated in the AMH:EGFP+ cell population compared to that in the control dH1 cells (CTRL) and AMH:EGFP- cells ([Figure 1F](#fig1){ref-type="fig"}). The specific expression of endogenous *AMH* in AMH:EGFP+ cells validated the function of the reporter to isolate the reprogrammed Sertoli cells from the mixed populations which might contain other cell types. Moreover, an epithelial marker expressed in Sertoli cells, that is, KRT18, was used to validate the transformation of the fibroblasts to Sertoli cells as one kind of epithelial cells. The cytoskeleton pattern of KRT18 expression was observed in the AMH:EGFP+ cells but not the control dH1 cells ([Figure 1G](#fig1){ref-type="fig"}).

Whole-genome transcriptional profiling of hiSCs resembling adult Sertoli cells {#s2-2}
------------------------------------------------------------------------------

To determine whether hiSCs reprogrammed with the 5TFs (5F-hiSCs) are similar to human Sertoli cells, we compared the transcriptomes of the AMH:EGFP+ 5F-hiSCs, dH1 cells infected with p2k7 empty virus (dH1-2K7) as negative controls, and primary adult Sertoli cells (aSCs) from human biopsy samples ([@bib58]). We focused our analysis on the differentially expressed genes (DEGs,\>2 fold change, p-value\<0.05) between 5F-hiSCs and dH1-2K7 and between aSCs and dH1-2K7. In total, 7533 genes were differentially expressed between 5F-hiSCs and dH1-2K7, including 4528 upregulated genes and 3005 downregulated genes ([Figure 2A and B](#fig2){ref-type="fig"}). Additionally, 5377 genes were differentially expressed between aSCs and dH1-2K7, including 3343 upregulated genes and 2034 down-regulated genes. The Venn analysis showed that 3626 genes were shared among the DEGs in both hiSCs and aSCs, accounting for approximately 67% of the DEGs in aSCs. Among this shared group of DEGs (CO-DEGs), 1973 genes were upregulated, while 1314 genes were down-regulated in both the hiSCs and aSCs ([Figure 2C](#fig2){ref-type="fig"}), indicating that the trends in transcriptional expression between the hiSCs and aSCs were the same in these genes. The cluster analysis of dH1-2K7, hiSCs and aSCs also showed that the CO-DEGs had a similar expression pattern between the hiSCs and aSCs, and consistency was observed between duplicate samples ([Figure 2D](#fig2){ref-type="fig"}). The Gene Ontology (GO) analysis of the CO-DEGs showed that among the 1973 upregulated genes, many genes were involved in the regulation of cell communication, regulation of immune response processes, response to hormones, and lipid metabolic process, whereas among the 1314 down-regulated genes, many genes were involved in the mitotic cell cycle and microtubule-based processes ([Figure 2E](#fig2){ref-type="fig"}). These changes in gene expression indicated that the hiSCs acquired unique cellular characteristics that were distinct from the original fibroblasts. To further confirm that the AMH:EGFP+ 5F-hiSCs have the signature of Sertoli cells, we examined the expression of several Sertoli cell markers, including *CLU, NCAM2, DHH, ERBB4, INHB, INHA, SHBG, GATA6, CDKN1B, TGFα* and *LMMA3*, by quantitative PCR (qPCR). Compared to the control cells, all Sertoli cell markers were highly enriched in the AMH:EGFP+ 5F-hiSCs ([Figure 2F](#fig2){ref-type="fig"}). Taken together, the transcriptional profile of the AMH:EGFP+ 5F-hiSCs resembled that of the aSCs, and many Sertoli cell markers were expressed.

![Whole genome transcriptional profiling of AMH:EGFP+ hiSCs.\
(**A**) Venn diagram to display differentially expressed genes (DEGs, FPKM value, fold change \>2) between dH1-2K7_vs_aSCs (n = 2) and dH1-2K7_vs_5F-hiSCs (n = 2). Intersection part represents the number of co-differentially expressed genes (CO-DEGs). (**B**) Summary of DEGs in (**A**). X axis represents upregulated DEGs and downregulated DEGs. Y axis represents DEGs numbers. Comparisons of different sample sets were represented by different colors. Black bar represents dH1-2K7_vs_5F-hiSCs. Gray bar represents dH1-2K7_vs_aSCs. (**C**) Summary of CO-DEGs in (**A**). X axis represents CO-DEGs number. Black bar represents co-upregulated DEGs. Gray bar represents co-downregulated DEGs. Dark gray bar and light gray bar represent CO-DEGs in opposite trend, respectively. (**D**) Heat map of gene expression of dH1-2K7, 5F-hiSCs and aSCs (n = 2 in each group). Red indicates upregulated expression, green indicates downregulated expression. (**E**) Functional enrichment analysis, biological processes of 1973 and 1314 differentially expressed genes were showed. (**F**) The mRNA level of Sertoli cell markers in dH1-2K7, AMH:EGFP- cells and AMH:EGFP+ cells, as measured by qPCR. Relative expression was normalized to dH1-2K7. GAPDH was used as the housekeeping gene. All data are presented as means ± SD, n = 2, \*p\<0.05, \*\*p\<0.01, Dunnett's test. three independent experiments were carried out.](elife-48767-fig2){#fig2}

NR5A1 and GATA4 are sufficient to reprogram fibroblasts to hiSCs as 5F-hiSCs {#s2-3}
----------------------------------------------------------------------------

Although the 5TFs yielded the AMH:EGFP+ hiSCs, the combination of all 5TFs may not be necessary to reprogram fibroblasts to hiSCs. Therefore, we used fewer transcription factors to generate hiSCs and compared the percentage of AMH:EGFP+ cells in all 31 combinations of NR5A1, GATA4, SOX9, WT1 and DMRT1. The FACS results indicated that 16 combinations of transcriptional factors yielded varying levels of AMH:EGFP+ cells after 10 days of reprogramming ([Figure 3A](#fig3){ref-type="fig"}). NR5A1 was the only common factor found in all 16 combinations in AMH:EGFP+ cells. This transcriptional factor alone generated approximately 3.79% of AMH:EGFP+ cells, and the combination of all 5TFs produced the highest percentage of AMH:EGFP+ cells. Surprisingly, the combinations with NR5A1 and GATA4 generated as many AMH:EGFP+ cells as all 5TF combined. Moreover, all combinations containing NR5A1 and GATA4 resulted in a similar level higher than the combinations with NR5A1 ([Figure 3B](#fig3){ref-type="fig"}). The AMH:EGFP+ cells generated by 2TFs and 5TFs showed similar morphologies, including a large cell body with an epithelial morphology, and expressed KRT18 ([Figures 1G](#fig1){ref-type="fig"} and [3C](#fig3){ref-type="fig"}).

![NR5A1 and GATA4 are sufficient to derive hiSCs.\
(**A**) Representative FACS results of different combinations of NR5A1, GATA4, WT1, SOX9 and DMRT1 for the induction of AMH:EGFP+ cells. dH1 fibroblasts were transduced with the indicated factors and reprogrammed for 10 days. The combinations were divided into three groups: -NR5A1, combinations without NR5A1; +NR5A1, combinations with NR5A1 but without GATA4; +NR5A1 and GATA4, combinations with both NR5A1 and GATA4. (**B**) Quantitative data of EGFP+ cells in (**A**). n = 2, biological replicates, error bar indicates SD, three independent combination experiments were conducted. \~10^4^ cells were analyzed in each experiment. (**C**) Immunofluorescent staining of KRT18 in 2F-hiSCs and dH1-2K7 after FACS. Scale bar = 100 μm. (**D**) Heat map of RNA-seq data illustrating differentially co-expressed genes. Red indicates upregulated expression, whereas green indicates downregulated expression. The genes were divided into three groups: Genes upregulated in 2F-hiSCs (dH1), 5F-hiSCs (dH1) and aSCs; genes upregulated in 5F-hiSCs (dH1) and aSCs but downregulated in 2F-hiSCs (dH1); genes downregulated in 2F-hiSCs (dH1), 5F-hiSCs (dH1) and aSCs; all compared to dH1-2K7. The gene number of each group was listed next to the map. Functional enrichment terms of each group and the representative genes were shown on the right side.](elife-48767-fig3){#fig3}

Then, we analyzed and compared the transcriptome of the 2F-hiSCs and with the transcriptome of the aSCs and 5F-hiSCs. We identified the common DEGs among the dH1/aSCs, dH1/5F-hiSCs (dH1), dH1/2F-hiSCs (dH1) and dH1/5F-hiSCs (HPF) and performed hierarchical clustering using their FPKM values. The analysis revealed that the transcriptome profiles of the 2F-hiSCs were more similar to the profiles of the 5F-hiSCs and adult Sertoli cells (aSCs) than to the dH1 and HPF profiles (data not shown). To identify the putative signature genes similar among the 2F-hiSCs, 5F-hiSCs and aSCs, we generated a heat map of the 1638 CO-DEGs and carried out gene correlation clustering. Notably, the differentially expressed genes were grouped into three groups of 512, 689 and 437 genes ([Figure 3D](#fig3){ref-type="fig"}). The Gene Ontology analysis showed that many of the 512 highly expressed genes mostly shared by the 2F-hiSCs, 5F-hiSCs and aSCs were involved in reproductive structure development, immune effector processes and response to hormones. These genes, including *KRT18*, *PTGDS* and *SOX9*, are used as markers of Sertoli cells or are highly expressed in Sertoli cells ([@bib8]; [@bib48]). We further compared the expression of 59 genes that are highly expressed in Sertoli cells ([@bib3]; [@bib4]; [@bib38]) among the 2F-hiSCs, 5F-hiSCs and aSCs. All three groups exhibited similar expression of many markers that are expressed in more mature Sertoli cells, including *CDKN1B* (or *p27^kip1^*) and *CLU* ([@bib55]). However, some markers in the aSCs, including *NCAM2*, *INHA* and *KRT18* ([@bib27]; [@bib55]), were expressed at lower levels ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) than those in the other two hiSCs. The Sertoli cell marker expression was very similar between the 2F-hiSCs and 5F-hiSCs. Principal component analysis (PCA) indicated that aSCs, 2F-hiSCs (dH1), 5F-hiSCs (dH1) clustered closely, confirming their co-expressed gene profiles are similar ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). SOX9 expressed at similar level in aSCs, dH1 and 2F-hiSCs but not in undifferentiated hESCs, showing that SOX9 expression increased after hESCs became fibroblasts, and maintained similar expression during 2F-hiSC formation ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Therefore, we focused on the 2F-hiSCs for the subsequent more thorough characterization.

Although we used AMH:EGFP reporter to isolate Sertoli-like cells, it was still possible that the isolated cells were Leydig cells. Hence, we examined whether the cells expressed any Leydig cell marker 3β-HSD ([@bib62]). We confirmed that neither 2F-hiSCs nor aSCs expressed any 3β-HSD ([Figure 3---figure supplement 4A](#fig3s4){ref-type="fig"}). Based on the RNA-sequencing results, we also confirmed other gene markers of Leydig cells were not detected or expressed at low level ([Figure 3---figure supplement 4B](#fig3s4){ref-type="fig"}).

We also validated that NR5A1 and GATA4 was able to reprogram primary human skin fibroblasts (HSF) and yielded AMH:EGFP+ hiSCs ([Figure 3---figure supplement 5A, B and C](#fig3s5){ref-type="fig"}). 12.9% of AMH:EGFP+ cells were induced after overexpression of the 2TFs. KRT18 were only detected in the AMH:EGFP+ cells after induction along with other genes enriched in Sertoli cells ([Figure 3---figure supplement 5D and E](#fig3s5){ref-type="fig"}). These results further supported that 2TFs can reprogram other primary human cell types.

2F-hiSCs attract human endothelial cells and accumulate lipid droplets {#s2-4}
----------------------------------------------------------------------

Sertoli cells mediate the migration of endothelial cells to seminiferous tubules during testicular cord formation ([@bib7]; [@bib13]). We investigated whether the hiSCs attracted human umbilical vein endothelial cells (HUVECs). The migration assay showed the number of HUVECs that were attracted and passed through the membrane was \~1.5 fold higher in both 2F-hiSCs and aSCs compared to the controls ([Figure 4A,B](#fig4){ref-type="fig"}). These results indicate that significantly more endothelial cells were attracted by the conditioned medium collected from the 2F-hiSCs than by that collected from the dH1-2K7 cells.

![2F-hiSCs attract endothelial cells and accumulate lipid droplets.\
(**A**) Mobility comparison of HUVECs incubated in conditioned medium collected from dH1-2K7, 2F-hiSCs and aSCs. Top, experimental diagram using the fluoroblok 24-multiwell insert plates with 8.0 μm pores. For observation, HUVEC were treated with 2.5 μM Calcein-AM fluorescent dye 1 hr prior to seeding. Down, fluorescent images showing cells passed through the pores. Conditioned medium collected from dH1-2K7 was used as control. Scar bar = 300 μm. (**B**) Summary of HUVEC cells crossing through the trans-well membrane. Each data point on the graph represents the number of cells in one separate image observed under 10 × fold microscope, area = 1690 × 1690 (μm). Error bars represent standard deviation of all the counted data points, n = 6, technical replicates, \*p\<0.05, \*\*p\<0.01, Student's t-test. two independent experiments were carried out. (**C**) BODIPY staining of lipid droplets in dH1-2K7, 2F-hiSCs and adult Sertoli cells (aSCs). All cells were fixed with 4% PFA and then stained with BODIPY for lipid droplets and DAPI for nucleus. Scar bar = 50 μm. (**D**) Each data point on the graph represents number of BODIPY+ cells in one separate image observed under 20 × fold microscope, area = 275 × 275 (μm). Error bars represent standard deviations of all the counted data points, \*p\<0.05, \*\*p\<0.01, Student's t-test. two independent experiments were carried out.](elife-48767-fig4){#fig4}

Another unique feature of Sertoli cells in humans and other mammalian species is the accumulation of lipid droplets in the cytoplasm ([@bib18]; [@bib53]). The Gene Ontology analysis showed that genes that participate in lipid metabolism processes were upregulated in the 2F-hiSCs, 5F-hiSCs and aSCs ([Figure 3D](#fig3){ref-type="fig"}), supporting the presence of high numbers of lipid droplets in the hiSCs. We used BODIPY to stain and count the number of cells with high numbers of lipid droplets to determine whether lipid droplets appeared in the 2F-hiSCs. The average percentage of cells that exhibited strong BODIPY positivity was approximately 15%, 40% and 60% in the control cells, 2F-hiSCs, and aSCs respectively ([Figure 4C,D](#fig4){ref-type="fig"}). Therefore, the percentage of cells containing high quantities of lipid droplets was higher in both 2F-hiSCs and aSCs than that in the dH1-2K7 cells. Oil-red O staining also confirmed the same result showing lipid droplet enrichment in 2F-hiSCs and aSCs ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

2F-hiSCs sustain in vitro culturing of mouse spermatogonia cells {#s2-5}
----------------------------------------------------------------

Mouse spermatogonia cells were isolated from seminiferous tubules of 6 dpp mice according to established protocols and co-cultured with dH1 or 2F-hiSCs to examine whether 2F-hiSCs sustain the growth of male germ cells ([Figure 5A](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A, B, C, D, E and F](#fig5s1){ref-type="fig"}). The observations that more mouse germ cells attached and survived on the 2F-hiSCs than dH1 cells began at approximately 12 hr of co-culturing ([Figure 5---figure supplement 1G](#fig5s1){ref-type="fig"}). The morphology of the round cells attached to the hiSCs appeared alive and resembled spermatogonia cells but the cells attached to dH1 appeared apoptotic and degenerated. After 48 hr of co-culturing, the samples were fixed and immunostained to further confirm that the 2F-hiSCs formed attachments with the spermatogonia cells. The immunostaining of the germ cell-specific marker DAZL (to identify mouse spermatogonia cells) and human-nuclear specific marker NuMA (to identify hiSCs and dH1) indicated that significantly more DAZL-positive spermatogonia cells attached to the hiSCs, but almost no DAZL-positive cells attached to the dH1 cells despite the similar numbers of plated hiSCs and dH1 cells ([Figure 5B and C](#fig5){ref-type="fig"}). Similar immunostaining patterns were observed when aSCs were co-cultured with mouse spermatogonia cells ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Sertoli cells directly contact male germ cells in seminiferous tubules in vivo, and we hypothesized that the hiSCs would directly contact the spermatogonia cells. We immunostained the co-cultured cells with DAZL and KRT18 and found that many DAZL-positive cells localized to areas occupied by hiSCs, typically at the edge of the cell bodies ([Figure 5D](#fig5){ref-type="fig"}).

![2F-hiSCs sustain the viability of mouse spermatogonia cells.\
(**A**) Timeline and steps of co-culturing hiSCs with mouse germ cells. (**B**) Immunofluorescent staining of germ cell marker, DAZL (green), and human specific marker, NuMA (red), in co-cultured mouse spermatogonia cells with 2F-hiSCs or dH1-2K7 48 hr after plating. DAPI (blue) was used to indicate the nucleus. Scale bar = 50 μm. (**C**) Summary of cell numbers on the co-cultured plate in (**B**). Each data point indicates the number of cells counted in one separate image observed under 20 × fold microscope, area = 330 × 330 (μm). Error bars are the standard deviations of all the counted data points. dH1-2K7 (n = 18, technical replicates from two separated experiments), 2F-hiSCs (n = 25, technical replicates from two separated experiments). \*p\<0.05, \*\*p\<0.01, Student's t-test. (**D**) Immunofluorescent staining of DAZL (green) and KRT18 (red) in co-cultured mouse spermatogonia cells and 2F-hiSCs 48 hr after plating. DAPI (blue) was used to indicate the nucleus. Scale bar = 50 μm. (**E**) Summary of cell numbers on the co-cultured plate in (**D**). Each data point indicates the number of cell counted in one separate image observed under 20 × fold microscope, area = 282 × 330 (μm). Error bars are the standard deviations of all the counted data points. dH1-2K7 (n = 4, technical replicates from two separated experiments), 2F-hiSCs (n = 9, technical replicates from two separated experiments). \*p\<0.05, \*\*p\<0.01, Student's t-test.](elife-48767-fig5){#fig5}

2F-hiSCs suppress T cell proliferation, IL-2 production and protect transplanted human cells {#s2-6}
--------------------------------------------------------------------------------------------

A specialized property of Sertoli cells is their functional role in creating an immune-privileged environment in seminiferous tubules to protect germ cells from immunological attacks. Previous studies have shown this unique function, which has been exploited in therapeutic transplantation for the protection of many other cell types ([@bib29]). We first investigated whether the medium from the 2F-hiSCs cells exhibited any suppressive effect on the proliferation of Jurkat E6 cells (human T lymphocytes) to examine whether the 2F-hiSCs could suppress the immunoreaction of immunological cells. The suppressive effect was evaluated using an assay commonly used to determine the active metabolism of a proliferating cell, that is, WST-1 ([@bib11]; [Figure 6A](#fig6){ref-type="fig"}). The Jurkat E6 cells were treated with various concentrations of 2F-hiSCs-conditioned medium or aSCs-conditioned medium and exhibited a significant dose-responsive decrease in cell proliferation compared to that in cells treated with dH1-2K7-conditioned medium ([Figure 6B](#fig6){ref-type="fig"}). The proliferation level was \~35% lower in the Jurkat lymphocytes exposed to the highest concentration of the 2F-hiSC-conditioned medium or aSCs-conditioned medium. We collected the Jurkat cells and analyzed the protein levels of interleukin-2 (IL-2), which plays an essential role in the immune system. The ELISA indicated that the IL-2 levels were significantly lower in the cells cultured with the 2F-hiSCs-conditioned or aSCs-condictioned medium than those in the cells cultured with the dH1-2K7-conditioned medium ([Figure 6C](#fig6){ref-type="fig"}, figure 6-figure supplement 1C). 22 genes previously known to participate in immune-modulation ([@bib28]; [@bib39]) or categorized as immune effector gene by gene ontology were activated after reprogramming of dH1 ([Figure 6D](#fig6){ref-type="fig"}), further supported that hiSCs acquired immunosuppressive function.

![2F-hiSCs exhibit immunosuppressive function and protect human cells in xenotransplantations.\
(**A**) Schematic illustration of the WST-1 assay to measure the inhibiting effect of 2F-hiSCs on Jurkat-E6 cell proliferation. Cleavage of the tetrazolium salt WST-1 by metabolically active cells results in the formation of formazon. The level of formazon is directly proportional to the proliferation level of the Jurkat cells. (**B**) Measurement of proliferation level in Jurkat cells treated with dH1-2K7, 2F-hiSCs or adult Sertoli cell (aSCs) conditioned medium. X axis represents the indicated proportion of conditioned medium tested in experiment. Conditioned medium from dH1-2K7 was used as a control. Values are presented as means ± SD and are from two separate experiments with each concentration tested in triplicate; Dunnett's test was carried out among samples at 80% CM, \*p\<0.05, \*\*p\<0.01. (**C**) Histogram showing the production of human IL-2 in lymphocytes treated by dH1-2K7 or 2F-hiSCs conditioned medium, as measured by ELISA. Error bars represent standard deviation of three technical duplicates from two separate experiments, \*p\<0.05, \*\*p\<0.01, Student's t-test. (**D**) A cluster of known immune-modulating genes for Sertoli cell immunoprotection. Relative gene expression level was indicated as red (upregulated) or green (downregulated). (**E**) Live imaging of luciferase-tracking assay 3 days to 10 days after transplantation. \~1.3 × 10^6^ 293 FT cells were subcutaneously injected into the indicated sites of the mouse \#1 with 2 × 10^5^ dH1-2K7 or 2F-hiSCs cells. Cell type and location of transplantation are indicated at left. Numbers in red represent primary readings of luciferase activity. The normalized fold change of luciferase cell activity between hiSCs and dH1-2K7 in each time point was summarized in the table.](elife-48767-fig6){#fig6}

Approximately, 1.3 × 10^6^ human 293FT cells stably integrated with a luciferase-expressing vector were co-transplanted with 2.5 × 10^5^ dH1-2K7, 2F-hiSCs or aSCs into mice with normal immune systems via hypodermic injection to determine whether the 2F-hiSCs could protect xenotransplanted cells. The transplantation experiment was performed to investigate the immunosuppressive effects at different locations (foreleg, hindleg, left and right sides of the animals as indicated on the figures) in different animals, and the transplanted sites were monitored for up to 10 days. D-luciferin was injected into the animals to follow the surviving transplanted 293FT cells, and the signal was monitored using live imaging 15 min post-injection beginning 3 days after transplantation. The transplanted 293FT cells gradually diminished in the immunocompetent mouse from day 3 to day 10 (mouse \#1, \#2) as indicated by the reduced luciferase activity at the transplanted sites ([Figure 6E](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). All 293FT cells co-transplanted with hiSCs exhibited higher luciferase activity, which ranged from 1.7- to 3.9-fold, 3 days after transplantation. Three of the four groups of transplanted cells survived until day 10, and two of the three groups of 293FT cells with hiSCs survived at least 10 days after transplantation with strong luciferase activity. In contrast, their counterpart control cells exhibited less than 40-fold or no detectable luciferase activity (mouse \#1 foreleg group and mouse \#2 hindleg group). Similar level of protection was observed when the same number of 293FT cells were transplanted with aSCs into mouse \#3 and \#4 ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). The transplants at day 10 were collected and dissected to examine the remaining cell types. NuMA staining indicated that there were many human cells survived in the transplants of 2F-hiSCs and some cells clustered together as cell aggregates ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}). These human cells could be 293FT cells or 2F-hiSCs. Positive immunostainings of NR5A1 confirmed the existence of 2F-hiSCs in the transplant but not the control transplant or the surrounding mouse tissue ([Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}).

hiSCs forms cell aggregates and do not actively proliferate {#s2-7}
-----------------------------------------------------------

Mouse Sertoli cells forms cell aggregates during in vitro culturing ([@bib8]). 2F-hiSCs also exhibited similar morphology of spherical cellular aggregates when cultured in 10% FBS on matrigel ([Figure 6---figure supplement 3A](#fig6s3){ref-type="fig"}). Different from the mouse Sertoli cells, we observed formation of partial ring-like structures when 2F-hiSCs were cultured in 2% FBS medium ([Figure 6---figure supplement 3B](#fig6s3){ref-type="fig"}). Adult human Sertoli cells tend to be more quiescent and less proliferative ([@bib48]). We examined the proliferation of 2F-hiSCs by EDU staining and found that these cells were not proliferative ([Figure 6---figure supplement 4A and B](#fig6s4){ref-type="fig"}).

CX43 deletion disrupts gap junctions and alters the expression profile of hiSCs {#s2-8}
-------------------------------------------------------------------------------

We investigated whether the deletion of the gap junction protein CX43 could affect hiSCs formation and determined whether hiSCs exhibit the same genetic requirements for development as Sertoli cells in vivo. We created a homozygous deletion of *CX43* hESC line, derived fibroblasts from this line and compared the reprogramming efficiency of the hiSCs ([Figure 7A](#fig7){ref-type="fig"}). We successfully generated three targeted mutations at *CX43*, that is, one single allele mutation (6\#) and two double allele mutations (21\# and 26\#) at Exon 2 of the *CX43* gene, using a CRISPR-CAS9 gene editing system ([Figure 7B](#fig7){ref-type="fig"}). The protein expression was completely disrupted in the CX43^-/-^ (21\#) and CX43^-/-^ (26\#) cell lines, but the heterozygous protein level remained similar to the wild-type CX43 level based on the Western blot analyses ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). The immunostaining of CX43 ([Figure 7C](#fig7){ref-type="fig"}) and photo bleaching assay ([Figure 7D and E](#fig7){ref-type="fig"}) of ES-derived fibroblasts (dH1) both showed that the expression of CX43 and gap junctions between neighboring cells were disrupted because there was no detectable CX43 staining or diffusing fluorescent dye recovered after photo bleaching in the CX43^-/-^ (26\#) cell line.

![CX43 regulates maturation of Sertoli cells.\
(**A**) Schematic diagram showing the comparison of 2F-hiSCs cells reprogrammed from *CX43* knock out fibroblasts and wild type fibroblasts. (**B**) *CX43* knockout design and the targeted sequences of indicated hESC lines. The knockout region was located in the second exon of the *CX43* gene. Three knockout cell lines were correctly targeted and mutated: one was heterozygous (06\#) and the other two were homozygous (21\# and 26\#). Dotted lines indicate deletion mutations, red triangles indicate insertion mutations. (**C**) Immunofluorescence analysis of CX43 (red) in wild type ES cell line (01\#) and knock out cell line (26\#). DAPI (blue) was used to indicate the nucleus. Scale bar = 20 μm. (**D**) Photo bleaching assay to test the Calcien AM transport ability of fibroblasts differentiated from wild type ES cell line (01\#) and knock out cell lines (26\#). (**E**) Measurement of Calcien AM signal over time after fluorescence bleaching. (**F**) Time course experiment during 2F-hiSCs reprogramming. The AMH:EGFP+ percentage resulted from three initial fibroblasts were tested: wild type dH1 (WT), CX43 knock out dH1 (CX43KO) and CX43 knock out plus CX43 overexpressed dH1 (OE CX43-CX43KO). (**G**) Summary of 2F-hiSCs reprogramming efficiency in (**F**). WT fibroblasts (WT) and CX43KO fibroblasts infected by p2k7 empty virus were also included. (**H**) Hierarchical clustering analysis using DEGs (FPKM value, fold change \>2) in [Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}. Genes were classified into eight parts according to their expression pattern in CX43 knock out dH1, CX43KO 2F-hiSCs, wild type dH1 and wild type 2F-hiSCs. Gene Ontology analysis of genes in part 2, 3, 7, eight was shown on the right respectively. Other groups were shown in [Figure 7---figure supplement 2C](#fig7s2){ref-type="fig"}. (**I**) Heat map indicating expression level of immature and mature Sertoli cell markers in WT and CX43KO 2F-hiSCs. Relative gene expression level was indicated as red (upregulated) or green (downregulated).](elife-48767-fig7){#fig7}

We compared the reprogramming efficiency of the 2F-hiSCs between the wild-type dH1 and CX43KO (CX43^-/-^ (\#26)) cell lines. The time course experiments showed that the percentage of AMH:EGFP+ in the WT hiSCs peaked at \~13.8% on day 15 and decreased to 3.3% on day 25 ([Figure 7F and G](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}). Remarkably, the percentage of AMH:EGFP+ in the CX43^-/-^ (\#26) cell line was 23.9% on day 15 and decreased to 18.5% on day 25, but the overexpression of CX43 in the deletion cell line revealed a much lower percentage of AMH:EGFP+ from days 4 to 25. Therefore, the expression level of CX43 in the cells was indirectly proportional to the percentage of AMH:EGFP+ cells. This result is consistent with the higher AMH expression in CX43 knockout mice reported in a previous study ([@bib57]) and suggests that the effect of the CX43 deletion leads to the dedifferentiation of Sertoli cells to a less mature state.

The high percentage of AMH:EGFP+ cells in the CX43KO cells may be due to their more immature status than that of WT AMH:EGFP+ hiSCs. Therefore, we compared the transcriptional profiles of these two populations to examine whether CX43KO affected gene expression or any cellular processes. The volcano analysis revealed that 2736 genes were differentially expressed (*p*-value less than 0.01) between the CX43KO 2F-hiSCs and WT 2F-hiSCs ([Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}). We found 754 genes with a difference in the transcript level greater than two-fold; 512 genes were down-regulated and 242 genes were upregulated in the CX43KO 2F-hiSCs compared to those in the WT 2F-hiSCs ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}). We further analyzed the 754 genes using a heat map and GO analysis to identify specific genes or processes affected by CX43KO. The genes were classified into eight gene sets according to the expression patterns among the WT dH1, WT 2F-hiSCs, CX43KO dH1 and CX43KO 2F-hiSCs ([Figure 7H](#fig7){ref-type="fig"}, [Figure 7---figure supplement 2C](#fig7s2){ref-type="fig"}). The genes in Groups 1 and 4 exhibited lower expression levels in the WT 2F-hiSCs and CX43 2F-hiSCs than in the other two groups of control cells, suggesting that these genes were affected by the reprogramming process. The genes in Groups 5 and 6 exhibited similar patterns between the WT cells and CX43KO cells, suggesting that these two groups were affected by CX43KO. In contrast, the expression profiles of the genes in Groups 2, 3, 7, and eight in the WT and CX43KO hiSCs differed from those in their counterpart controls and between the WT and CX43KO hiSCs. These genes may reflect the cellular maturation status of these two reprogrammed cell populations. The GO analysis of enriched terms in these four groups revealed that Group two was enriched with genes involved in catabolic processes, including nucleobase-containing compound catabolic process, and Group three contained genes involved in steroid metabolic or lipid biosynthetic processes. Group seven included many genes that participated in the cytoskeleton, and Group eight contained genes related to gamete generation.

Ten marker genes previously reported to be more highly expressed in mature or immature Sertoli cells ([@bib48]; [@bib55]) were chosen for the expression level comparisons between WT and CX43KO hiSCs. The CX43KO hiSCs exhibited a higher expression of some immature markers and lower expression of mature markers, suggesting that the CX43KO cells were more immature than the WT hiSCs.

Discussion {#s3}
==========

This study reported that human fibroblasts can be reprogrammed to Sertoli-like cells using 5TFs (NR5A1, GATA4, WT1, DMRT1 and SOX9) or 2TFs (NR5A1 and GATA4). Fibroblasts from two sources, that is, human pulmonary fibroblasts and fibroblasts derived from human embryonic stem cells, were reprogrammed to Sertoli-like cells and exhibited transcriptomes similar to those of primary adult Sertoli cells. The present study generated a Sertoli cell-specific gene reporter, that is, AMH:EGFP, to enhance the efficiency of isolating a relatively pure population of hiSCs from a mixed population of cells at different reprogramming stages ([Figure 1](#fig1){ref-type="fig"}). AMH has been used in many conditioned knockout studies to specify the expression of Cre recombinase in mouse Sertoli cells ([@bib34]). Recent single-cell transcriptome study of adult human testicular cells indeed confirmed that AMH is specifically expressed in Sertoli cells but not other somatic cells or germ cells ([@bib56]). We cloned the human promoter of *AMH* and fused it to EGFP and showed that the cell population expressing EGFP appeared only after reprogramming, and these cells expressed many Sertoli cell marker genes. This isolation step eliminates the possibility that the reprogrammed cells we studied were other somatic cells such as Leydig cells which share some gene markers. The success of reprogramming human fibroblasts with the same factors used in a previous mouse study ([@bib8]) confirms that the reprogramming capability of these 5TFs is conserved between humans and mice.

Another achievement of this study was the reduction in the reprogramming factors from 5TFs to 2TFs. NR5A1, which is often called SF1, was the most essential of the five factors because almost no AMH:EGFP+ cells appeared in the reprogramming experiments without NR5A1, even if GATA4, WT1, DMRT1 and SOX9 were overexpressed ([Figure 3A and B](#fig3){ref-type="fig"}). Notably, only the addition of GATA4, but not the addition of the three other TFs, to the reprogramming combination increased the percentage of AMH:EGFP+ cells. Several TFs, including NR5A1 and GATA4, are key regulators establishing the mouse Sertoli cell identity ([@bib45]). Therefore, unsurprisingly, NR5A1 and GATA4 were sufficient to reprogram human fibroblasts to Sertoli-like cells. WT1 and SOX9 are also determining factors in mouse Sertoli cells, but their reprogramming abilities were lower than those of NR5A1 and GATA4. SOX9 interacts with NR5A1 to trigger the specific onset of AMH expression ([@bib45]), but SOX9 overexpression in our reprogramming experiments only slightly increased the percentage of AMH:EGFP+ cells in a few combinations of TFs ([Figure 3A and B](#fig3){ref-type="fig"}).

The cellular characterizations of the 2F-hiSCs showed that these cells carried many known properties of Sertoli cells. Lipid metabolism in Sertoli cells is important for providing nutritional and energy supplies to germ cells ([@bib18]). Previous studies have shown that the high metabolic activity requirements for lipid and steroid synthesis are associated with the differentiated status of Sertoli cells ([@bib24]). Notably, the hiSCs in the present study exhibited a high expression of lipid and steroid related genes ([Figure 3D](#fig3){ref-type="fig"}), and the WT hiSCs exhibited a higher expression than the CX43KO hiSCs ([Figure 7H](#fig7){ref-type="fig"}). These results suggest that the hiSCs were similar to terminally differentiated Sertoli cells in vivo. The lipid droplet staining assays clearly showed the presence of high numbers of lipid droplets in the hiSCs but not the fibroblasts used for reprogramming ([Figure 4C](#fig4){ref-type="fig"}).

Sustaining the viability and differentiation of spermatogonia cells is the most essential function of Sertoli cells. We examined the ability of hiSCs to sustain mouse spermatogonia cells because of the inaccessible procurement of human spermatogonia cells from hospitals. Previous studies performing xenotransplantation experiments transplanting primate spermatogonia stem cells into mouse testis demonstrated that primate germ cells colonized in the seminiferous tubules of the recipient mice, but the primate germ cells did not differentiate because of the evolutionary differences between these species ([@bib41]). The isolated mouse spermatogonia cells in our study attached and survived on the hiSCs, but no differentiated spermatocytes were detected ([Figure 5B](#fig5){ref-type="fig"}; data not shown). These results suggest that the reprogrammed Sertoli cells were only capable of providing a niche for the survival of male germ cells in vitro. Recent studies have reported in vitro derivations of immature human gametes from hESCs ([@bib15]; [@bib25]; [@bib30]). The male and female gametes in these studies were immature likely due to the absence of fully competent somatic cells in the differentiating culture. Therefore, adding induced Sertoli cells or granulosa cells to in vitro differentiating cultures may be a key step in obtaining fully functional gametes in vitro.

Another prominent role of Sertoli cells is the creation of an immune-privileged environment to protect germ cells from immune attacks of lymphocytes. Many studies have documented that Sertoli cells secrete factors that suppress the proliferation of T cells, B cells and NK cells ([@bib28]; [@bib36]), including the suppression of IL-2 from T cells ([@bib47]). Our results indicate that culture medium incubated with hiSCs suppress the proliferation of Jurkat cells (the immortalized cell line of human T lymphocytes) and reduce IL-2 production in Jurkat cells treated with hiSC-conditioned medium ([Figure 6B and C](#fig6){ref-type="fig"}). Many genes previously known to participate in immune effector processes were upregulated in the hiSCs compared to those in fibroblasts ([Figure 6D](#fig6){ref-type="fig"}), suggesting that hiSCs modulate immune suppression via multiple immunological pathways. Notably, all 293FT cells co-transplanted with hiSCs into two different immunocompetent mice survived longer than their counterpart control cells co-transplanted with fibroblasts ([Figure 6E](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}). These results suggest that the hiSCs protected the xenotransplanted 293FT cells from host immune cells. Previous studies have reported that Sertoli cells protect many cell types in allogenic and xenogenic transplantation, and several studies used immunosuppressive drugs or immune-deficient mice in long-term follow-up experiments ([@bib29]; [@bib39]). One study xenotransplanted porcine Sertoli cells with rat islet cells into the kidney capsule of immunocompetent rats ([@bib61]). The islet allografts survived 8 to 9 days when 1.5 × 10^6^ porcine Sertoli cells were co-transplanted. In our experiments, 2.5 × 10^5^ hiSCs were co-transplanted with 293FT cells and survived at least 10 days in two mice. Therefore, our xenotransplanted 293FT cells survived a similar or longer duration with lower numbers of reprogrammed human Sertoli cells in immunocompetent mice. Long-term transplantations of hiSCs with clinically relevant cell types, including pancreatic islets and skin grafts, should be investigated for potential clinical applications, such as the treatment of diabetes and skin burns. Our hiSCs have the advantage of being of human origin, which alleviates the issue of xenotransplantation and potential of animal virus infection.

Reprogrammed Sertoli cells may be used as a model for examining the cellular and genetic mechanisms of human Sertoli cell biology. A previous study reported an association between Sertoli-only syndrome (SCO) and the lower mRNA expression of CX43 ([@bib14]) and suggested that the absence of CX43 rendered the Sertoli cells more immature. However, the precise mechanism by which the absence of CX43 causes infertility is unclear. Our studies revealed that multiple pathways, including lipid metabolism and nucleobase catabolism, were more highly expressed in the WT than in the CX43KO hiSCs, indicating that the absence of CX43 disrupts these molecular pathways in Sertoli cells. The expression of several markers of immature Sertoli cells was higher and the expression of markers of mature Sertoli cells was lower in CX43KO than in the WT hiSCs. Taken together, our results suggest that the deletion of CX43 disrupts multiple molecular pathways and delays the maturation of Sertoli cells. Infertility in men may be caused by genetic mutations in germ cells or Sertoli cells. Genetic or cellular defects in Sertoli cells have not been well studied to understand how they cause infertility due to a lack of in vitro model of human Sertoli cells. Our in vitro induced system now provides a platform for basic research and potential treatment of male infertility caused by Sertoli cells in the future.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                    Designation                                                                             Source or reference                             Identifiers                                                                            Additional\
  (species) or\                                                                                                                                                                                                                                                                   information
  resource                                                                                                                                                                                                                                                                        
  ------------------------------------------------ --------------------------------------------------------------------------------------- ----------------------------------------------- -------------------------------------------------------------------------------------- -------------------------------------------------------
  Mouse                                            C57BL/6                                                                                 Vital River Laboratory Animal Technology                                                                                               

  Cell line (*Homo-sapiens*)                       293FT cells                                                                             Thermo Fisher Scientific                        Cat\# R70007                                                                           

  Cell line (*Homo-sapiens*)                       H1 ES cells                                                                             WiCell Research Institute                       Cat\# WA01                                                                             

  Cell line (*Homo-sapiens*)                       Human Pulmonary Fibroblasts                                                             National Infrastructure of Cell Line Resource   Cat\# CCC-HPF-1 (PUMC, Beijing)                                                        

  Transfected construct (*Homo-sapiens*)           p2k7-EF1alpha-NR5A1                                                                     This paper                                                                                                                             Lentiviral construct to express target gene

  Transfected construct (*Homo-sapiens*)           p2k7-EF1alpha-GATA4                                                                     This paper                                                                                                                             Lentiviral construct to express target gene

  Transfected construct (*Homo-sapiens*)           p2k7-EF1alpha-SOX9                                                                      This paper                                                                                                                             Lentiviral construct to express target gene

  Transfected construct (*Homo-sapiens*)           p2k7-EF1alpha-WT1                                                                       This paper                                                                                                                             Lentiviral construct to express target gene

  Transfected construct (*Homo-sapiens*)           p2k7-EF1alpha-DMRT1                                                                     This paper                                                                                                                             Lentiviral construct to express target gene

  Transfected construct                            p2k7-EF1alpha-luciferin                                                                 This paper                                                                                                                             Lentiviral construct to express target gene

  Transfected construct (*Homo-sapiens*)           p2k7-EF1alpha-CX43                                                                      This paper                                                                                                                             Lentiviral construct to express target gene

  Recombinant DNA reagent                          p2k7-AMH-GFP                                                                            This paper                                                                                                                             Lentiviral construct for AMH reporter

  Recombinant DNA reagent                          pX335-U6-Chimeric_BB-CBh-hSpCas9n(D10A)                                                 Addgene \#42335                                                                                                                        Expressing Cas9 and gRNA ([@bib12])

  Biological sample (*Homo-sapiens*)               Primary adult human Sertoli cells                                                       Shanghai Jiao Tong University                                                                                                          Freshly isolated

  Antibody                                         anti-DAZL(Mouse polyclonal)                                                             AbD Serotec                                     Cat\#: MCA2336; RRID: [AB_2292585](https://scicrunch.org/resolver/AB_2292585)          IF(1:50)

  Antibody                                         anti-NuMA (Rabbit polyclonal)                                                           Abcam                                           Cat\#: Ab97585; RRID: [AB_GR27454-16](https://scicrunch.org/resolver/AB_GR27454-16)    IF(1:100)

  Antibody                                         anti-human KRT18 (Rabbit polyclonal)                                                    Proteintech                                     10830--1-AP                                                                            IF(1:100)

  Antibody                                         anti-SOX9 (Rabbit monoclonal)                                                           Abcam                                           Cat\#: Ab170660; RRID: [AB_GR155689-1](https://scicrunch.org/resolver/AB_GR155689-1)   IF(1:100)

  Antibody                                         anti-human CX43 (Rabbit polyclonal)                                                     Cell Sigaling                                   Cat\#: 3512S                                                                           IF(1:100)

  Antibody                                         anti-human DMRT1 (Rabbit polyclonal)                                                    Abcam                                           Cat\#: Ab1786                                                                          IF(1:100)

  Antibody                                         anti-human WT1 (Rabbit polyclonal)                                                      Proteintech                                     Cat\#: 12609--1-AP                                                                     IF(1:100)

  Antibody                                         anti-human GATA4 (Rabbit polyclonal)                                                    Proteintech                                     Cat\#: 19530--1-AP                                                                     IF(1:100)

  Antibody                                         anti-human NR5A1 (Rabbit polyclonal)                                                    Proteintech                                     Cat\#: 18658--1-AP                                                                     IF(1:100)

  Antibody                                         donkey anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488   Invitrogen                                      Cat\#: A-21202; RRID: [AB_141607](https://scicrunch.org/resolver/AB_141607)            IF(1:1000)

  Antibody                                         donkey anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 555   Invitrogen                                      Cat\#: A-31572; RRID: [AB_1567203](https://scicrunch.org/resolver/AB_1567203)          IF(1:1000)

  Strain, strain background (*Escherichia coli*)   TransStbl3 Chemically Competent Cell                                                    TransGen Biotech                                Cat\#: CD521                                                                           

  Peptide, recombinant protein                     bFGF, Recombinant Human FGF basic Protein                                               R and D Systems                                 Cat\#: 233-FB-CF                                                                       

  Chemical compound, drug                          G418, Geneticin                                                                         Thermo Fisher Scientific                        Cat\#: 10131035                                                                        

  Chemical compound, drug                          Blasticidin                                                                             Thermo Fisher Scientific                        Cat\#: R21002                                                                          

  Software, algorithm, website                     ImageJ                                                                                  NIH                                                                                                                                    <https://imagej.nih.gov/ij/>

  Software, algorithm, website                     FlowJo (v10.3)                                                                          BD                                                                                                                                     <https://www.flowjo.com>

  Software, algorithm, website                     Prism7 (v7.0 a)                                                                         Graphpad Software                                                                                                                      <https://www.graphpad.com/scientific-software/prism/>

  Software, algorithm                              DAVID Bioinformatics Resources (v6.8; GO)                                                                                                                                                                                      <https://david.ncifcrf.gov>

  Software, algorithm, website                     Tophat2/cufflinks                                                                       ([@bib31])                                                                                                                             <http://ccb.jhu.edu/software/tophat>

  Software, algorithm, website                     R (v3.4.1; PCA, cluster and DEG)                                                                                                                                                                                               <https://www.R-project.org>

  Other                                            DAPI stain                                                                              Invitrogen                                      D1306                                                                                  (1 µg/mL)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Experimental model and subject details {#s4-1}
--------------------------------------

### Animal Care and Use {#s4-1-1}

C57BL/6 mice were purchased from Vital River Laboratory Animal Technology Co., Ltd (Beijing, China). All animal maintenance and experimental procedures were performed according to the guidelines of the Institutional Animal Care and Use Committee (IACUC) of Tsinghua University, Beijing, China.

### Cell Lines {#s4-1-2}

Human ES cell line used in this study were H1 (XY), purchased from WiCell, Inc Undifferentiated H1 were maintained on MEF feeder cells as previous described ([@bib25]). All cells were cultured at 37°C in a humidified incubator supplied with 5% CO~2~. ES medium were standard knockout serum replacer (KSR) consisted of 20% knockout serum replacer, 0.1 mM nonessential amino acids, 1 mM L-glutamine, 0.1 mM -mercaptoethanol, and 4 ng/ml recombinant human basic fibroblast growth factor (bFGF, R and D systems).

To obtain adherent fibroblast differentiation, human ESC clones were first transferred to 1% Matrigel coated plates by colony picking using a glass needle and cultured in ES cell conditioned medium (ES medium incubated overnight on irradiated MEFs) for \~5 days to remove all the residual MEF cells. Differentiation of hESCs to fibroblasts (dH1) began after aspirating of conditioned medium, washing with PBS without Ca^2+^ and Mg^2+^ twice, and replacing with differentiation medium (knockout DMEM with 20% fetal bovine serum, 0.1 mM nonessential amino acids, 1 mM L-glutamine). Differentiation medium was changed every 3 days. When the cell reached 90% confluency (\~7 days), the resulting dH1 were collected and kept in liquid nitrogen tank for long time preservation or passaged by the ratio 1:3 if more cells were needed.

Primary human pulmonary fibroblasts (HPF) were purchased from National Infrastructure of Cell Line Resource. Primary human skin fibroblast (HSF) was a gift from Professor Ting Chen at National Institute of Biological Sciences, Beijing, and prepared according to the published protocol ([@bib44]). Human adult Sertoli cells were a generous gift from Professor Zheng Li at Shanghai Jiao Tong University and prepared according to the established protocol ([@bib58]). The HPF and HSF cells were maintained at 75 ml culture flask in 15 ml DMEM culture medium (Corning) containing 10% FBS (Gibco), 0.1 mM nonessential amino acids and 1 mM L-glutamine. Primary adult Sertoli cells were cultured as previously described in DF12 medium consisting of DMEM/F12% and 10% FBS (Gibco) and passaged every 5 days when cell confluence reached 80%.

Human umbilical vein endothelial cells (HUVEC) were a gift from Professor Jie Na at Tsinghua University. HUVECs were cultured in ECM medium (Sciencell) containing 10% FBS (Gibco) and passaged every 3 days when cell confluence reached 80%.

All of the cells above were cultured in a 37°C humidified incubator supplied with 5% CO~2~.

Method details {#s4-2}
--------------

### Overexpression vector construction and lentivirus production {#s4-2-1}

All overexpression vectors carrying EF1α promoter and desired gene were constructed using the Gateway system (Invitrogen) as previously described ([@bib25]). Briefly, the candidate cDNA was first introduced into pENTR/1A or pENTR/D-topo donor vectors and transferred to 2K7 destination vectors with EF1α promoter in pENTR/5' topo by LR recombination ([@bib50]). Modified destination plasmids containing the cDNA were then introduced into 293FT cells together with the helper plasmids vsvg and ∆8.9 by LIPO3000 (Invitrogen) transfection to produce virus. Approximately, a total of 37 ml of virus supernatant was harvested on day1 and day3 after transfection and filtered with a 0.45 μm filter. At the time of virus infection, 8 μg/ml of polybrene was supplemented to increase infection efficiency.

### AMH:EGFP reporter and creating reporter cell line {#s4-2-2}

1.6 kb of human *AMH* promoter upstream of the transcriptional start site was PCR amplified from genomic DNA of 293FT cells and cloned to pENTR5'-TOPO. Cloned plasmids were then recombined with pENTR/D-TOPO that carried the EGFP cDNA to create p2K7-AMH:EGFP recombinant plasmid and generated lentiviral supernatant as described above in overexpression vector construction section. Fibroblast HPF or dH1 in early passage (with 50% confluence) were transduced overnight on plate in fibroblast medium and recovered for one day after removal of virus. Subsequent drug selection by blasticidin (10 μg/ml) required another 3 days. Selected human fibroblasts were passaged for two times to expand the cell number for further experiments or frozen in liquid nitrogen.

### hiSC reprogramming and enrichment by FACS {#s4-2-3}

Sertoli-like cell reprogramming was carried out in a T75 flask coated with Matrigel (1%). In brief, 1.5 × 10^5^ human fibroblast cells carrying AMH:GFP reporter were seeded into T75 flask 1 day prior to overnight transduction with lentivirus NR5A1, GATA4, DMRT1, SOX9 and WT1 (for 5F-hiSCs) or NR5A1 and GATA4 (for 2F-hiSCs), recovered for 24 hr, following by drug selection with geneticin (1 mg/ml) for 5 days in MEF medium. After drug selection, transduced cells were cultured in DF12 medium, maintained for the indicated reprogramming duration, and harvested for FACS by digestion with TrypLE Express (Invitrogen). The single cell suspension for FACS was prepared with MACS medium (10% FBS in PBS with 0.0125 mM EDTA) and filtrated through a BD cell sorter. Cell sorting was proceeded on a high-speed cell sorter (Influx, BD) and was sorted to collecting tube containing DF12 medium.

Experiment aiming at examining different combinations of reprogramming factors was performed in six well plates and all possible combinations of NR5A1, GATA4, DMRT1, SOX9 and WT1 were tested. At the time of virus infection, 200 ul of each virus was added per well, and brought to the same final volume of 1 ml with p2k7 empty virus.

### Quantitative PCR and statistical analysis {#s4-2-4}

Quantitative PCR was conducted as previously described ([@bib25]). Briefly, total RNA was collected according to the instructions provided by QIAGEN RNeasy kit (QIAGEN) or TRIZOL (Invitrogen). CDNA was generated by EasyScript One-Step gDNA Removal and cDNA Synthesis SuperMix kit (TRANSGEN) according to manufacturer's protocols using up to 500 ng RNA for each sample. 20 μl reaction (for Bio-rad 96-well System) were prepared and conducted with TransStart Green qPCR SuperMix kit (TRANSGEN). Gene expression was calculated using Bio-Rad CFX Manager program for relative expression formulation (dC(t)) and normalized to housekeeping genes (ACTB or GAPDH). Then, the gene expression of different samples were again normalized to the expression of control cells infected by p2k7 empty virus (CTRL) and reported as fold change ([@bib52]). Statistical analysis was carried out using Student's t-test or one-way ANOVA by Prism 6.0 software.

### RNA sequencing {#s4-2-5}

\~2.5 × 10^5^ cells were collected by FACS and total RNA was extracted by TRIZOL (Invitrogen). The quality and integrity of the purified RNAs were checked by Agilent 2100 bioanalyzer. Qualified RNA from the following samples was used for RNA Sequencing analysis: (1) HPF or dH1 carrying AMH:EGFP reporter, transduced with empty virus p2k7 and followed the same reprogramming procedure as described above. (2) Day10 hiSCs generated with five factors (5F-hiSCs) or generated with two factors (2F-hiSCs). (3) Human primary adult Sertoli cells (aSCs) cultured in vitro in DMEMF12 medium + 10% FBS. Sequencing libraries preparation and sequencing operations were carried out by ANNOROAD, a company providing RNA sequencing service, complied with the whole set of processes from Illumina.

### Immunofluorescence of cultured cells {#s4-2-6}

Dissociated cells from FACS enrichment were collected onto a slide by Cytospin (800 r.p.m. for 5 min) or replated onto a 6-well plate. After that, cells were washed one time with PBS, fixed in 4% paraformaldehyde for 10 min and treated with 2.5% Triton X-100 for 15 min. For antibodies staining, slides were first blocked in 2.5% donkey serum for 1 hr, then incubated overnight in 4°C with primary antibody (1:200 for KRT18, 1:100 for NuMA, 1:200 for CX43, 1:100 for VASA, all rabbit-derived, Abcam; 1:50 for DAZL, mouse-derived, AbD Serotec; 1:100 for NR5A1, GATA4, WT1, SOX9, DMRT1, all rabbit-derived, Proteintech). Slides were then washed five times (each 3 min) with PBST (0.1% Tween-20/PBS), followed by anti-rabbit secondary antibodies (anti-rabbit-555 or anti-rabbit-488, Invitrogen) incubating for 1 hr at room temperature and washing for another five times. All sections were then mounted with Prolong Diamond Anti-Fade Mounting Reagent (ThermoFisher) and cover slip.

### Effect of 2F-hiSCs conditioned medium on Jurkat cell proliferation and IL-2 production {#s4-2-7}

1 ml conditioned medium were collected from 3.5 × 10^4^ of 2F-hiSCs or dH1-2K7 fibroblast (control) cultured at 50% confluence 48 hr after plating. For each assay, 2 × 10^4^ human T lymphocytes (Jurkat E6-1 cells, gift from Professor Hai Qi, Tsinghua University) were seeded in 1 well of 96-well plate with 120 μl 1064 medium with 10% FBS, 0.1 mM nonessential amino acids, 1 mM L-glutamine, 0.1 mM--mercaptoethanol and added with indicated amount of conditioned medium from either 2F-hiSCs or dH1-2K7 (as control). The Jurkat cells were then cultured in a 37°C incubator with 5% CO~2~ for 3 days. Metabolism of WST-1 was used to determine the proliferative ability of lymphocytes in each well according to manufacturer's instructions (Beyotime, Co., Ltd.). Three hours prior to analysis, 12 μl of WST-1 was added to each well and the final absorbance was measured by a microplate reader at 450 nm (SPECTRA max PLUS, Molecular Devices Inc). 1064 medium alone with WST-1 was used as a control to subtract background absorbance. For IL-2 quantification, 2 × 10^5^ of Jurkat cells were seeded in one 6-well plate containing either 50% 2F-hiSCs or dH1-2K7 conditioned medium and cultured for 3 days. Then, cells were collected and lysed with 20 μl RIPA buffer. The concentration of IL-2 was determined by ELISA kit according to the manufacturer's instructions (Cusabio Biotech, Co., Ltd.).

### Cell migration assays {#s4-2-8}

Confluent P8 HUVEC cells were cultured with fresh ECM medium overnight before experiment. Then cells were incubated with medium containing 2.5 μM Calcein-AM fluorescent dye for one hour in incubator supplied with 37°C, 5% CO~2~. Cells were then trypsinized, counted and suspended in migration medium (50% ECM+50% MEF medium). Migration assays were carried out in Corning FluoroBlok 24-multiwell insert plate with 8.0 μm pores (Cat. No. 351157. Corning). Prior to seeding HUVEC (150 k, in 100 μl volume) into the insert, 50% conditioned medium pre-incubated with hiSCs or dH1 was mixed with 50% ECM and added to the basal chamber (600 μl in total). Following incubation of HUVECs at 37°C, 5% CO2 needed for 20 hr. The migration cells passed through the membrane were monitored by Calcein-AM with the help of an inverted microscope (Leica) at 485/535 nm (Ex/Em). Images were captured using Leica-Pro software provided by the microscope company. The number of migration cell was measured by calculating of the Calcein-AM green signal of each image.

### Mouse spermatogonia isolation and coculture with 2F-hiSCs {#s4-2-9}

Mouse spermatogonia cells were isolated from \~24 testis of C57BL/6 mice at day six after birth according to previous protocol with minor modifications ([@bib26]; [@bib54]). Briefly, the decapsulated testis and seminiferous tubules were detached with the help of tweezers. After washing with DPBS for three times, the seminiferous tubules were transferred to a new 15 ml tube and subjected to enzymatic digestion. Firstly, the seminiferous tubules were digested with 1 mg/ml collagenase IV for 5 min at 37°C in a water bath with shaking, then centrifuged at 50 × g to collect the segregated tubules and washed three times with DMEM/F12 medium. The small fragments were resuspended in 2 ml culture medium composed of DMEM/F12 medium with 10% FBS and seeded on 2 wells of 6-well plates (Corning) and incubated at incubator supplied with 37°C, 5% CO2. After attachment for 24 hr, the somatic cells were tightly attached to the dish and formed patches, while spermatogonia were just loosely attached on the somatic cells. The spermatogonia were then transferred to a new plate coated with 1% matrigel and cultured for two passages in the medium (DMEM/F12 medium, 20% KSR, 100 × Glutamax, 100 × NEAA, 100 × Pen/Strep, human GDNF 20 ng/mL, human bFGF 5 ng/mL). 24 hr prior to co-culturing experiments,\~1.5 × 10^5^ dH1 or 2F-hiSCs were plated to 1 well of the 48 well plate. The spermatogonia cells were collected by gently washing with fresh medium and transferred to the well plated with the dH1 or 2F-hiSCs in DMEM/F12 medium with 10% FBS.

### Co-transplantation of hiSCs with 293FT cells {#s4-2-10}

All animal experiments were approved by the Institutional Animal Care and Use Committees at Tsinghua University. \~ 1.3 × 10^6^ number of 293FT cells stably transduced with a luciferase reporter were mixed with 2.5 × 10^5^ cells of either dH1 or 2F-hiSCs in 100 μl Matrigel. The suspension was transplanted into C57BL/6 (Purchased from Vital River Laboratory Animal Technology) mice with normal immune system by subcutaneous injection. Live imaging of transplanted mice was performed at the indicative day after transplantation. 15 min prior to live imaging, 100 μl of D-luciferin (15 mg/ml, 10 μL/g mouse weight) was injected to the mice by intraperitoneal injection and luciferase activity was measured in the IVIS Spectrum machine (PerkinElmer Health Sciences, Inc).

### BODIPY and Oil Red O staining of lipid droplets {#s4-2-11}

Cells were washed with PBS and fixed with 4% PFA for 15 min. For BODIPY staining, cells were stained with BODIPY (Invitrogen, working solution1 μg/ml) at room temperature for 15 min and washed in PBS for three times. Then, mounted cells with Prolong gold anti-fade reagent (Invitrogen).

For Oil Red O staining, 0.5% Oil Red O Stock Solution (in isopropanol) was used. Staining solution contains 6 parts of stock Oil Red O and 4 parts of distilled water, filtered with Whitman paper before used. After cell fixation, stained the cells with 1 ml staining solution for 15 min, then clear background using 60% isopropanol. Finally, wash with distilled water.

### Cell lines {#s4-2-12}

All primary cells and cell lines have been tested to confirm no mycoplasma contamination before they were used in the experiments. Information about three established cell lines 293FT, H1 and CCC-HPF-1 were listed in the key resource table. None of the cell line is found in the list of misidentified cell lines maintained by the International Cell Line Authentication Committee.

Quantification and statistical analysis {#s4-3}
---------------------------------------

Statistical details of analysis including statistical test used, value of n and statistical significance were all described in the figure legends.

### RNA-seq data processing {#s4-3-1}

All RNA-seq data were mapped to human genome build hg19 (UCSC) by TopHat (version 2.1.1), reads from PCR duplicates were dropped. The gene expression level was calculated by Cufflinks (version 2.2.1) using the protein coding genes GTF file extracted from Ensembl database (Homo_sapiens.GRCh37.75.gtf). Read counts were obtained using HTSeq (version 0.9.1). Differentially expressed genes (DEGs) were analyzed using R package DESeq2 and selected using p-value\<0.01 as a threshold. Heat map was plotted using heatmap.2 function of R, and gene expressions were scaled to FPKM or Z-scores. We used R function cor to do sample correlation clustering and principal component analysis (PCA). K-means clustering was performed using Cluster 3.0 package (K = 3, Spearman Correlation, Complete-linkage) and clustered heat maps were produced by TreeView.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Your study nicely translates previous studies on reprogramming to the Sertoli lineage, provides a nice tool to model fertility syndromes and could potentially be utilized for clinical efforts aimed at fertility issues.

**Decision letter after peer review:**

Thank you for submitting your article \"Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Utpal Banerjee as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers and this editor generally agree that this manuscript represents an important advance in the generation of human Sertoli cells, and goes beyond previously published work in mouse models. However, the reviewers raised several important issues that, if addressed, could potentially make the study acceptable for *eLife*.

Essential revisions:

All of the reviewer comments are relevant, and none appeared to raise issues that are beyond the scope of the study. We hope that you can carefully and thoughtfully respond to these reviews, with new data, where applicable.

Reviewer \#1:

This study establishes methodology for direct reprogramming of human fibroblasts in Sertoli-like cells via expression of transcription factors expressed in fetal Sertoli cells. Given the dependence of spermatogonia upon somatic support cells, deriving human Sertoli cells is an important step toward the goal of producing mature gametes in vitro.

This is a thorough and careful study in which the authors optimize the number and combination of factors for reprogramming, show that fibroblasts from two different sources can be reprogrammed, and interrogate gene expression and function in the cells they derive. Functional tests include chemoattraction of endothelial cells, suppression of T cell proliferation, accumulation of lipid droplets, and capacity to support mouse spermatogonial survival. The most definitive test of function for in vitro-derived Sertoli cells would be their demonstrated support of complete spermatogenesis, however a barrier to this revealed by previous work of others is the failure of primate spermatogonia to complete maturation in the mouse testis. The most reasonable alternative is a transplant into non-human primate testes, which lies beyond the scope of the current study. Finally, the demonstration that connexin 43 deficient fibroblasts cannot produce Sertoli-like cells with equivalent function adds to rigor of the work. The results and approaches are well described in the figures and with cartoons.

Reviewer \#2:

In this study, human fibroblast was first reprogrammed into Sertoli-like cells with five transcriptional factors and a gene reporter carrying the AMH promoter. they further reduce the number of reprogramming factors to two, NR5A1 and GATA4, and show that the hiSCs have transcriptome profiles and cellular properties that are similar to those of primary human Sertoli cells. The function of hiSCs was further tested by sustain of mouse spermatogonia cells, suppress the proliferation of human T lymphocytes and protect xenotransplanted human cells in mice. They also find that 2F-hiSCs attract human endothelial cells and accumulate lipid droplets. This is the first time induce human fibroblast to transform into Sertoli-like cells, the results are potentially interesting. The in vitro induced system provides a platform for basic research and potential treatment of male infertility in the future. However, there are several issues need to be addressed.

1\) In this study, AMH was used as a reporter to identify the hiSCs. It has been reported that AMH is abundantly expressed in mouse Sertoli cells during embryonic stage and AMH protein is not detected in Sertoli cells after birth. The expression of AMH is probably different from other species. It is necessary to examine the expression of AMH in human Sertoli cells by immunostaining. The specificity of AMH promoter also need to be verified by transfecting human adult Sertoli cells.

2\) The authors claim that human fibroblasts could be transformed into hiSCs by two TFs. WT1 and SOX9 are two very important marker genes, loss of WT1 results in defect of Sertoli function and germ cell loss. In this study, the expression of endogenous WT1 and SOX9 in two TFs induced hiSCs need to be examined by immunostaining and other approaches.

3\) The lipid droplet was stained with BODIPY, it is very hard to tell the morphology of lipid droplet. Oil Red O staining is suggested to examine the morphology of lipid droplet in hiSCs and control Sertoli cells.

4\) SF1 is a very important TF for steroidogenic cell development and many genes which involved in steroidogenesis are induced by SF1. The authors only examined the expression of 3β-HSD, the expression of other genes also need to be examined in hiSCs.

Reviewer \#3:

Liang et al. report experiments in which they have transdifferentiated human fibroblast cells into Sertoli-like cells (hiSCs) that are morphologically, physiologically, and transcriptionally similar to adult human Sertoli cells. Moreover, they successfully reduced the number of transcription factors necessary for cell reprogramming from five to two. The authors have displayed an incredible amount of work, and their results have considerable implications for infertility treatment in humans. However, this is a rehash of the mouse work with no conceptional advancement from what was done by the Church lab.

\- Were all TFs in separate plasmids or were the RNAs being expressed from a single promoter. There is significant variability in 5TF expression in the IF data. Actually how many of the transformed cells express multiple TFs.

\- In Figure 1D -- there is no clear separation or conversion of HPF to AMH:EGFP+ cells. The dH1 induced Sertoli cells still look very much fibroblasty. Do these cells express *SOX9*?

\- Although the authors demonstrate a strong trend of similarity between hiSCs and aSCs, their analysis nonetheless clearly demonstrates that differences remain between these groups (e.g., there are numerous transcriptomic differences visible in Figure 2). However, the authors never detail what the differences between hiSCs and aSCs are.

\- The PCA plot Hierarchical clustering needs to be shown when comparing 5TF, 2TF, vs. aSCs. The authors opted not to include the data.

\- aSCs make for an important positive control, but a direct comparison between aSCs and hiSCs is often missing (e.g. co-plating isolated spermatogonia with SCs; human IL-2 assay (Figure 6C); luciferase assay in xenotransplants; and CX43 deletion experiments).

\- Methods on germ cell/Sertoli cell coculture need to be further detailed -- what strain of mice was used for SSC culture. A two day culture is not sufficient to show the 2F Sertoli cells can support germ cell maintenance -- comparing this to aSC is important.

\- In the CX43 experiment it's not clear why the authors think loss of CX43 affect Sertoli cell specification when in humans the testis has Sertoli cells but actually males don\'t have germ cells. Also it\'s not clear why they would see an increase in reprogramming efficiency or decrease when overexpression. It is unclear how the authors concluded that CX43 deletion lead to dedifferentiation of Sertoli cells to a less mature state (subsection "CX43 deletion disrupts gap junctions and alters the expression profile of hiSCs", second paragraph). If you mix with germ cells can the Sertoli cells differentiate. why not stain with SOX9 -- this is not affected by maturation.

\- It was frequently unclear how many cells were used in a given replicate or how many replicates were included in an experiment.

\- Authors should use consistent labeling in their graphs (e.g. \"2K7\" vs. \"CTRL\") and use the same scale (and ideally range) for their axes. The scale of the y-axes in Figure 4B are confusing.
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Author response

> Reviewer \#2:
>
> \[...\] 1) In this study, AMH was used as a reporter to identify the hiSCs. It has been reported that AMH is abundantly expressed in mouse Sertoli cells during embryonic stage and AMH protein is not detected in Sertoli cells after birth. The expression of AMH is probably different from other species. It is necessary to examine the expression of AMH in human Sertoli cells by immunostaining. The specificity of AMH promoter also need to be verified by transfecting human adult Sertoli cells.

AMH expression is expressed in adult human Sertoli cell although the expression may be relatively lower than embryonic Sertoli cells. This is supported by the recent single-cell sequencing study of adult human testis by an independent research group (Wang et al., 2018). They concluded that AMH is specifically expressed in Sertoli cells but not in other somatic cells including Leydig cells of adult human testis. (See Figure 1D from Wang et al., 2018).

We have also confirmed the specificity of AMH promoter and expression of EGFP in our reporter system by transfecting the vector into human adult Sertoli cells (Figure 1---figure supplement 3).

> 2\) The authors claim that human fibroblasts could be transformed into hiSCs by two TFs. WT1 and SOX9 are two very important marker genes, loss of WT1 results in defect of Sertoli function and germ cell loss. In this study, the expression of endogenous WT1 and SOX9 in two TFs induced hiSCs need to be examined by immunostaining and other approaches.

We examined the transcriptional level of WT1 and SOX9 by RNA-seq and found that WT1 expression in both aSCs and 2F-hiSCs was relatively low but SOX9 expression in both aSCs and 2F-hiSCs was similar (Figure 3---figure supplement 1). When we tried to immunostain WT1, we were not able to detect the proteins in the nuclei of both cell types (data not shown). However, we detected similar level of SOX9 in the nuclei of aSCs and 2F-hiSCs (Figure 3---figure supplement 3). The immunostaining results are consistent with the RNA-seq results. We speculate that WT1 may be important during in vivo development of Sertoli cells, but it may not be important during in vitro reprogramming of fibroblasts to Sertoli cells.

> 3\) The lipid droplet was stained with BODIPY, it is very hard to tell the morphology of lipid droplet. Oil Red O staining is suggested to examine the morphology of lipid droplet in hiSCs and control Sertoli cells.

We have used Oil Red O staining to examine the existence of lipid droplet and found that red lipid droplets appeared in both aSCs and 2F-hiSCs but not in control cells (Figure 4---figure supplement 1).

> 4\) SF1 is a very important TF for steroidogenic cell development and many genes which involved in steroidogenesis are induced by SF1. The authors only examined the expression of 3β-HSD, the expression of other genes also need to be examined in hiSCs.

Beside 3β-HSD, we have examined the transcriptional level of many other genes expressed in steroidogenic Leydig cells. We found that most of these genes (8 out of 10) are not detectable or expressed at very low level (Figure 3---figure supplement 4B). Two of these genes were detectable (STAR and PGD), but they are also expressed in aSCs.

> Reviewer \#3:
>
> \[...\] The authors have displayed an incredible amount of work, and their results have considerable implications for infertility treatment in humans. However, this is a rehash of the mouse work with no conceptional advancement from what was done by the Church lab.
>
> \- Were all TFs in separate plasmids or were the RNAs being expressed from a single promoter. There is significant variability in 5TF expression in the IF data. Actually how many of the transformed cells express multiple TFs.

Each TF was cloned separately into lentiviral plasmid so each gene was expressed from its own promoter (human EF1alpha). Figure 1A showed the fibroblasts transduced with lentivirus of each TF plasmid. The first experiment aim was to confirm that the transduced fibroblasts expressed high level of each TF in the expected subcellular location, nucleus. When we mixed all five TFs to obtain AMH:EGFP+ cells, we detected high expression of all five TFs (Figure 3---figure supplement 1).

> \- In Figure 1D -- there is no clear separation or conversion of HPF to AMH:EGFP+ cells. The dH1 induced Sertoli cells still look very much fibroblasty. Do these cells express SOX9?

After TF induction, AMH:EGFP+ cells from both HPF and dH1 fibroblasts undergo morphological changes. This was shown in Figure 1E. In contrast to dH1 transduced with p2k7 control cell that showed fibroblast morphology, AMH:EGFP+ cells became more epithelial-like morphology. These cells expressed SOX9 as shown in Figure 3---figure supplement 1 (RNA expression) and Figure 3---figure supplement 3 (protein expression).

> \- Although the authors demonstrate a strong trend of similarity between hiSCs and aSCs, their analysis nonetheless clearly demonstrates that differences remain between these groups (e.g., there are numerous transcriptomic differences visible in Figure 2). However, the authors never detail what the differences between hiSCs and aSCs are.

We compared the characteristics of hiSCs to aSCs and used aSCs as a positive control. Indeed, more of the characteristics are similar between these two cell types. There were some minor differences such as expression level of some genes as shown in Figure 3---figure supplement 1. However, the overall transcriptional profiles are similar as in Figure 2D and PCA analysis in Figure 3---figure supplement 2.

> \- The PCA plot Hierarchical clustering needs to be shown when comparing 5TF, 2TF, vs. aSCs. The authors opted not to include the data.

We have added PCA plot in Figure 3---figure supplement 2 and showed that 2F-, 5F-hiSCs and aSCs clustered closely but distanced away from fibroblasts.

> \- aSCs make for an important positive control, but a direct comparison between aSCs and hiSCs is often missing (e.g. co-plating isolated spermatogonia with SCs; human IL-2 assay (Figure 6C); luciferase assay in xenotransplants; and CX43 deletion experiments).

In the previous version of manuscript, we used aSCs in some experiments including xenotransplants (Figure 6---figure supplement 1B). In the revised manuscript, we have added more control experiments using aSCs, including co-plating with isolated spermatogonia (Figure 5---figure supplement 2), IL-2 assays (Figure 6---figure supplement 1C). We are not able to create CX43 deletion cell lines in aSCs because they are primary cells and not proliferative. In addition, the original goal of CX43 experiment is to determine whether CX43 is important during Sertoli cell formation or induction. aSCs is not an ideal positive control in this experiment.

> \- Methods on germ cell/Sertoli cell coculture need to be further detailed -- what strain of mice was used for SSC culture. A two day culture is not sufficient to show the 2F Sertoli cells can support germ cell maintenance -- comparing this to aSC is important.

We described the information about the mouse strain (C57BL/6) we used in the SSC experiments in the Materials and methods section under 'Co-transplantation of hiSCs with 293FT cells'.

> \- In the CX43 experiment it's not clear why the authors think loss of CX43 affect Sertoli cell specification when in humans the testis has Sertoli cells but actually males don\'t have germ cells. Also it\'s not clear why they would see an increase in reprogramming efficiency or decrease when overexpression. It is unclear how the authors concluded that CX43 deletion lead to dedifferentiation of Sertoli cells to a less mature state (subsection "CX43 deletion disrupts gap junctions and alters the expression profile of hiSCs", second paragraph). If you mix with germ cells can the Sertoli cells differentiate. why not stain with SOX9 -- this is not affected by maturation.

First, we observed the expression of several markers of immature Sertoli cells was higher and the expression of markers of mature Sertoli cells was lower in CX43KO than in the WT hiSCs (Figure 7I). Second, a previous study reported an association between Sertoli-only syndrome (SCO) and the lower mRNA expression of CX43 (Defamie et al., 2003) and suggested that the absence of CX43 rendered the Sertoli cells more immature.

AMH is a gene expresses higher in immature Sertoli cells and we used AMH:EGFP+ to measure the reprogramming efficiency. Hence, the fact that CX43KO cell lines yielded higher AMH:EGFP+ percentage is consistent with the RNA-seq result showing that CX43KO cells expressed more immature Sertoli markers.

> \- It was frequently unclear how many cells were used in a given replicate or how many replicates were included in an experiment.

We have indicated the number of cells and number of replicates in the figure legends. Please let us know which number is missing and we will add the information.

> \- Authors should use consistent labeling in their graphs (e.g. \"2K7\" vs. \"CTRL\") and use the same scale (and ideally range) for their axes. The scale of the y-axes in Figure 4B are confusing.

We apologized that the labeling of control were different in different figures. We were considering to change all labels as CTRL, but there are more than one control cell type in certain sets of experiments, e.g. Figure 3D. Hence, we went through the figures and added more information to the controls whenever it is not clear. Please let us know if there is any control we need to clarify.
